Skip to main content
Top
Published in:

01-04-2023 | Mood Disorders | Research

Co-alteration Network Architecture of Major Depressive Disorder: A Multi-modal Neuroimaging Assessment of Large-scale Disease Effects

Authors: Jodie P. Gray, Jordi Manuello, Aaron F. Alexander-Bloch, Cassandra Leonardo, Crystal Franklin, Ki Sueng Choi, Franco Cauda, Tommaso Costa, John Blangero, David C. Glahn, Helen S. Mayberg, Peter T. Fox

Published in: Neuroinformatics | Issue 2/2023

Login to get access

Abstract

Major depressive disorder (MDD) exhibits diverse symptomology and neuroimaging studies report widespread disruption of key brain areas. Numerous theories underpinning the network degeneration hypothesis (NDH) posit that neuropsychiatric diseases selectively target brain areas via meaningful network mechanisms rather than as indistinct disease effects. The present study tests the hypothesis that MDD is a network-based disorder, both structurally and functionally. Coordinate-based meta-analysis and Activation Likelihood Estimation (CBMA-ALE) were used to assess the convergence of findings from 92 previously published studies in depression. An extension of CBMA-ALE was then used to generate a node-and-edge network model representing the co-alteration of brain areas impacted by MDD. Standardized measures of graph theoretical network architecture were assessed. Co-alteration patterns among the meta-analytic MDD nodes were then tested in independent, clinical T1-weighted structural magnetic resonance imaging (MRI) and resting-state functional (rs-fMRI) data. Differences in co-alteration profiles between MDD patients and healthy controls, as well as between controls and clinical subgroups of MDD patients, were assessed. A 65-node 144-edge co-alteration network model was derived for MDD. Testing of co-alteration profiles in replication data using the MDD nodes provided distinction between MDD and healthy controls in structural data. However, co-alteration profiles were not distinguished between patients and controls in rs-fMRI data. Improved distinction between patients and healthy controls was observed in clinically homogenous MDD subgroups in T1 data. MDD abnormalities demonstrated both structural and functional network architecture, though only structural networks exhibited between-groups differences. Our findings suggest improved utility of structural co-alteration networks for ongoing biomarker development.
Appendix
Available only for authorised users
Literature
go back to reference Olvera, R. L., Bearden, C. E., Velligan, D. I., et al. (2011). Common Genetic Influences on Depression, Alcohol and Substance Use Disorders in Mexican-American Families. American Journal of Medical Genetics Part b: Neuropsychiatric Genetics, 156B(5), 561–568. https://doi.org/10.1002/ajmg.b.31196CrossRef Olvera, R. L., Bearden, C. E., Velligan, D. I., et al. (2011). Common Genetic Influences on Depression, Alcohol and Substance Use Disorders in Mexican-American Families. American Journal of Medical Genetics Part b: Neuropsychiatric Genetics, 156B(5), 561–568. https://​doi.​org/​10.​1002/​ajmg.​b.​31196CrossRef
Metadata
Title
Co-alteration Network Architecture of Major Depressive Disorder: A Multi-modal Neuroimaging Assessment of Large-scale Disease Effects
Authors
Jodie P. Gray
Jordi Manuello
Aaron F. Alexander-Bloch
Cassandra Leonardo
Crystal Franklin
Ki Sueng Choi
Franco Cauda
Tommaso Costa
John Blangero
David C. Glahn
Helen S. Mayberg
Peter T. Fox
Publication date
01-04-2023
Publisher
Springer US
Published in
Neuroinformatics / Issue 2/2023
Print ISSN: 1539-2791
Electronic ISSN: 1559-0089
DOI
https://doi.org/10.1007/s12021-022-09614-2

Other articles of this Issue 2/2023

Neuroinformatics 2/2023 Go to the issue

Advances in Alzheimer's

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Learn more